- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Apr 30, 2025 | 116.7M sh |
| Shares Diluted | Q2 2025 · Mar 29, 2025 | 119.4M sh |
| Shares Diluted | Q2 2025 · Mar 29, 2025 | 118.8M sh |
| Shares Diluted | Q2 2025 · Mar 30, 2024 | 118.2M sh |
| Shares Diluted | Q2 2025 · Mar 30, 2024 | 118.5M sh |
| Stock Repurchased | Q2 2025 · Mar 29, 2025 | $0 |
| Stock Repurchased | Q2 2025 · Mar 30, 2024 | $88M |
| Dividends Paid | Q2 2025 · Mar 29, 2025 | $80M |
| Dividends Paid | Q2 2025 · Mar 30, 2024 | $70M |
| Capex | Q2 2025 · Mar 29, 2025 | $257M |
| Capex restated | Q2 2025 · Mar 30, 2024 | $292M |
| Operating Cash Flow | Q2 2025 · Mar 29, 2025 | −$321M |
| Operating Cash Flow | Q2 2025 · Mar 30, 2024 | $0 |
| Cash And Equivalents | Q2 2025 · Mar 29, 2025 | $483M |
| Cash And Equivalents | Q2 2025 · Sep 28, 2024 | $865M |
| Stockholders Equity | Q2 2025 · Mar 29, 2025 | $2.48B |
| Stockholders Equity | Q2 2025 · Sep 28, 2024 | $3.61B |
| Current Liabilities | Q2 2025 · Mar 29, 2025 | $3.62B |
| Current Liabilities | Q2 2025 · Sep 28, 2024 | $3.67B |
| Total Liabilities | Q2 2025 · Mar 29, 2025 | $10.41B |
| Total Liabilities | Q2 2025 · Sep 28, 2024 | $13.01B |
| Current Assets | Q2 2025 · Mar 29, 2025 | $3.31B |
| Current Assets | Q2 2025 · Sep 28, 2024 | $4.57B |
| Total Assets | Q2 2025 · Mar 29, 2025 | $12.88B |
| Total Assets | Q2 2025 · Sep 28, 2024 | $16.61B |
| Eps Diluted | Q2 2025 · Mar 29, 2025 | $1.62 |
| Eps Diluted | Q2 2025 · Mar 29, 2025 | $1.74 |
| Eps Diluted | Q2 2025 · Mar 30, 2024 | $0.98 |
| Eps Diluted | Q2 2025 · Mar 30, 2024 | $1.48 |
| Eps Basic | Q2 2025 · Mar 29, 2025 | $1.66 |
| Eps Basic | Q2 2025 · Mar 29, 2025 | $1.79 |
| Eps Basic | Q2 2025 · Mar 30, 2024 | $1.00 |
| Eps Basic | Q2 2025 · Mar 30, 2024 | $1.51 |
| Sga Expense | Q2 2025 · Mar 29, 2025 | $200M |
| Sga Expense | Q2 2025 · Mar 29, 2025 | $423M |
| Sga Expense restated | Q2 2025 · Mar 30, 2024 | $187M |
| Sga Expense restated | Q2 2025 · Mar 30, 2024 | $393M |
| Net Income | Q2 2025 · Mar 29, 2025 | $193M |
| Net Income | Q2 2025 · Mar 29, 2025 | $207M |
| Net Income | Q2 2025 · Mar 30, 2024 | $116M |
| Net Income | Q2 2025 · Mar 30, 2024 | $175M |
| Operating Income | Q2 2025 · Mar 29, 2025 | $391M |
| Operating Income | Q2 2025 · Mar 29, 2025 | $543M |
| Operating Income restated | Q2 2025 · Mar 30, 2024 | $182M |
| Operating Income restated | Q2 2025 · Mar 30, 2024 | $347M |
| Cost Of Revenue | Q2 2025 · Mar 29, 2025 | $2.02B |
| Cost Of Revenue | Q2 2025 · Mar 29, 2025 | $3.95B |
| Cost Of Revenue restated | Q2 2025 · Mar 30, 2024 | $2.02B |
| Cost Of Revenue restated | Q2 2025 · Mar 30, 2024 | $3.92B |
| Revenue | Q2 2025 · Mar 29, 2025 | $2.52B |
| Revenue | Q2 2025 · Mar 29, 2025 | $4.91B |
| Revenue restated | Q2 2025 · Mar 30, 2024 | $2.52B |
| Revenue restated | Q2 2025 · Mar 30, 2024 | $4.85B |